Purple Biotech Ltd. Updates Company Presentation

Ticker: PPBT · Form: 6-K · Filed: May 6, 2025 · CIK: 1614744

Sentiment: neutral

Topics: company-update, investor-relations, presentation

Related Tickers: PRPL

TL;DR

Purple Biotech (PRPL) dropped an updated investor deck on their site today.

AI Summary

On May 6, 2025, Purple Biotech Ltd. made available an updated Company Presentation on its website. This presentation is attached as Exhibit 99.1 to the 6-K filing. The company was formerly known as Kitov Pharma Ltd. and Kitov Pharmaceuticals Holdings Ltd.

Why It Matters

Investors can access the latest company information and strategic updates directly from Purple Biotech Ltd.'s official presentation.

Risk Assessment

Risk Level: low — This filing is an informational update (Company Presentation) and does not contain new financial or operational disclosures that would significantly alter risk.

Key Players & Entities

FAQ

What is the purpose of this 6-K filing?

The purpose of this 6-K filing is to report that Purple Biotech Ltd. has made available an updated Company Presentation on its website as of May 6, 2025.

Where can the updated Company Presentation be found?

The updated Company Presentation is attached to the 6-K filing as Exhibit 99.1 and can be viewed on the Company's website.

What was Purple Biotech Ltd. previously known as?

Purple Biotech Ltd. was formerly known as Kitov Pharma Ltd. and Kitov Pharmaceuticals Holdings Ltd.

What is the filing date of this report?

This report was filed on May 6, 2025.

What is the SIC code for Purple Biotech Ltd.?

The Standard Industrial Classification (SIC) code for Purple Biotech Ltd. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 6, 2025 regarding PURPLE BIOTECH LTD. (PPBT).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing